Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum β-lactamase-producing Klebsiella pneumoniae isolated in Portugal

International Journal of Antimicrobial Agents

Volumn 34, Issue 1, 2009, Pages 29-37

  Mendonça, Nuno ^a   Ferreira, Eugénia ^a   Louro, Deolinda ^a   Caniça, Manuela ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Antibiotic resistance; ESBL; Genotype; Klebsiella pneumoniae; Portugal; SHV type

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; BETA LACTAMASE; COTRIMOXAZOLE; QUINOLONE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; GENOTYPE; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; NUCLEOTIDE SEQUENCE; PORTUGAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLUSTER ANALYSIS; DNA FINGERPRINTING; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PORTUGAL; SEQUENCE ANALYSIS, DNA;

EID: 67349159730     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.11.014     Document Type: Article

References (34)

1. Ambler R.P., Coulson A.F., Frère J.M., Ghuysen J.M., Joris B., Forsman M., et al. A standard numbering scheme for the class A β-lactamases. Biochem J 276 (1991) 269-270
2. Bush K., Jacoby G.A., and Medeiros A.A. A functional classification scheme for β-lactamases and its correlation with molecular structures. Antimicrob Agents Chemother 39 (1995) 1211-1233
3. Babini G.S., Livermore D.M., and Are S.H.V. β-lactamases universal in Klebsiella pneumoniae?. Antimicrob Agents Chemother 44 (2000) 2230
4. Paterson D.L., and Bonomo R.A. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18 (2005) 657-686
5. SHV gene. Antimicrob Agents Chemother 52 (2008) 441-445
6. Romero L., López L., Rodríguez-Baño J., Hernández J.R., Martínez-Martínez L., and Pascual A. Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases. Clin Microbiol Infect 11 (2005) 625-631
7. Lee S.Y., Kotapati S., Kuti J.L., Nightingale C.H., and Nicolau D.P. Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae species on clinical outcomes and hospital costs: a matched cohort study. Infect Control Hosp Epidemiol 27 (2006) 1226-1232
8. Peterson L.R. Antibiotic policy and prescribing strategies for therapy of extended-spectrum β-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin Microbiol Infect 14 (2008) 181-184
9. Bell J.M., Chitsaz M., Turnidge J.D., Barton M., Walters L.J., and Jones R.N. Prevalence and significance of a negative extended-spectrum β-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific surveillance program. J Clin Microbiol 45 (2007) 1478-1482
10. Caccamo M., Perilli M., Celenza G., Bonfiglio G., Tempera G., and Amicosante G. Occurrence of extended spectrum β-lactamases among isolates of Enterobacteriaceae from urinary tract infections in southern Italy. Microb Drug Resist 12 (2006) 257-264
11. Zhanel G.G., Hisanaga T.L., Laing N.M., DeCorby M.R., Nichol K.A., Palatnick L.P., et al. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 26 (2005) 380-388
12. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections. In: Olmsted R.N. (Ed). APIC infection control and applied epidemiology: principles and practice (1996), Mosby, St Louis, MO A1-A20
13. Mendonça N., Leitão J., Manageiro V., Ferreira E., and Caniça M. Spread of clinical extended-spectrum β-lactamase (CTX-M)-producing Escherichia coli isolates in community and nosocomial environments in Portugal. Antimicrob Agents Chemother 51 (2007) 1946-1955
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 17th informational supplement. M100-S17. Wayne, PA: CLSI; 2007.
15. Cavallo JD, Chardon H, Chidiac C, Choutet P, Courvalin P, Dabernat H, et al. Recommandations 2007. Paris, France: Comité de l'Antibiogramme de la Société Française de Microbiologie; 2007.
16. Caniça M.M., Barthelemy M., Gilly L., Labia R., Krishnamoorthy R., and Paul G. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type β-lactamases. Antimicrob Agents Chemother 41 (1997) 374-378
17. Mendonça N., Ferreira E., Louro D., and Caniça M. Occurrence of a novel SHV-type enzyme (SHV-55) among isolates of Klebsiella pneumoniae from Portuguese origin in a comparison study for extended-spectrum β-lactamase-producing evaluation. Diagn Microbiol Infect Dis 56 (2006) 415-420
18. Sutcliffe G. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc Natl Acad Sci USA 75 (1978) 3737-3741
19. Pitout J.D.D. Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8 (2008) 159-166
20. Heritage J., M'zali F.H., Gascoyne-Binzi D., and Hawkey D.M. Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria. J Antimicrob Chemother 44 (1999) 303-318
21. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS Project. J Antimicrob Chemother 51 (2003) 69-76
22. Raymond J., Nordmann P., Doit C., Thien H.V., Guibert M., Ferroni A., et al. Multidrug-resistant bacteria in hospitalised children: a 5-year multicenter study. Pediatrics 119 (2007) 798-803
23. Luzzaro F., Mezzatesta M., Mugnaioli C., Perilli M., Stefani S., Amicosante G., et al. Trends in production of extended-spectrum β-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J Clin Microbiol 44 (2006) 1659-1664
24. Turnidge J., Bell J., Biedenbach D.J., and Jones R.N. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999. Int J Antimicrob Agents 20 (2002) 10-17
25. Sader H.S., Fritsche T.R., and Jones R.N. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003). Diagn Microbiol Infect Dis 52 (2005) 265-273
26. Tumbarello M., Spanu T., Sanguinetti M., Citton R., Montuori E., Leone F., et al. Bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 50 (2006) 498-504
27. Goossens H., Ferech M., Stichele R.V., Elseviers M., and ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross national database study. Lancet 365 (2005) 579-587
28. Deshpande L.M., Jones R.N., Fritsche T.R., and Sader H.S. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY antimicrobial surveillance program (2000-2004). Microb Drug Resist 12 (2006) 223-230
29. Barroso H., Freitas-Vieira A., Lito L.M., Cristino J.M., Salgado M.J., Neto H.F., et al. Survey of Klebsiella pneumoniae producing extended-spectrum β-lactamases at a Portuguese hospital: TEM-10 as the endemic enzyme. J Antimicrob Chemother 45 (2000) 611-616
30. Duarte A., Boavida F., Grosso F., and Correia M. Outbreak of GES-1 β-lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal. Antimicrob Agents Chemother 47 (2003) 1481-1482
31. Cantón R., and Coque T.M. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 9 (2006) 466-475
32. Livermore D.M., Canton R., Gniadkowski M., Nordmann P., Rossolini G.M., Arlet G., et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59 (2007) 165-174
33. Mugnaioli C., Luzzaro F., De Luca F., Brigante G., Perilli M., Amicosante G., et al. CTX-M-type extended-spectrum β-lactamases in Italy: molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 50 (2006) 2700-2706
34. Machado E., Coque T.M., Cantón R., Novais A., Sousa J.C., Baquero F., et al. High diversity of extended-spectrum β-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 60 (2007) 1370-1374